Recently, a subsidiary of Innovita Biological Technology (688253.SH) has obtained a qualification.
Yinuote (688253.SH) announced that its wholly-owned subsidiary, Yinuote (Tangshan) Biotechnology Co., Ltd...
Innovita Biological Technology (688253.SH) announced that its wholly-owned subsidiary, Innovita Biological Technology (Tangshan) Biotechnology Co., Ltd. (referred to as "Tangshan Innovita Biological Technology"), has recently obtained a new product qualification for a product named Norovirus GI/GII nucleic acid detection kit (PCR fluorescence probe method).
The acquisition of the above qualification has broadened the company's product range, further enhancing the company's market expansion capability and core competitiveness.
Related Articles
ZYLOXTB(02190) spent 85,500 Hong Kong dollars on July 18 to repurchase 4000 shares.
GF SEC (01776) completed the issuance of 1.4 billion yuan subordinate company bonds.
Northchip's life sciences board's IPO has been approved, focusing on precision diagnosis and treatment of cardiovascular diseases in Innovative Medical Management equipment production and research and sales.
ZYLOXTB(02190) spent 85,500 Hong Kong dollars on July 18 to repurchase 4000 shares.
GF SEC (01776) completed the issuance of 1.4 billion yuan subordinate company bonds.
Northchip's life sciences board's IPO has been approved, focusing on precision diagnosis and treatment of cardiovascular diseases in Innovative Medical Management equipment production and research and sales.
RECOMMEND
For the Third Consecutive Month, China Reduces U.S. Treasury Holdings by $900 Million in May, While Japan and the United Kingdom Increase Holdings
18/07/2025
Tariff-Driven Inflation Arrives with Delay as U.S. Consumers Begin to Feel the Initial Pinch
18/07/2025
Multiple Countries in High-Stakes Talks with the U.S.; EU Considers Invoking “Anti-Coercion Tool” as U.S. Plans Unified Tariffs on 150 Nations
18/07/2025
